The Russian-made Covid-19 vaccine, Sputnik V, is expected to be approved by the Indian regulator in the coming weeks, according to Dr. Reddy’s Laboratories.
“We foresee obtaining clearance within the next few weeks. It comes in two doses. The first dose is given on day 0 and the second on day 21. Between days 28 and 42, the immune system reaches its height. So it’s a two-dose vaccine that should be available in the coming weeks “According to news agency PTI, Deepak Sapra, the company’s CEO of APIs and Services, said.
Sapra was asked how soon Sputnik will be available and whether it would be a one-dose or two-dose vaccine during a webinar today evening.
Dr. Reddy’s Laboratories and the Russia Direct Investment Fund (RDIF) have teamed up to introduce the Sputnik V vaccine to India and other countries.
According to the journal Lancet, trials of the vaccine were performed in Russia, India, the United Arab Emirates, and other nations, and the Covid-19 vaccine showed effectiveness of 91.6 percent.
The trial data is currently with the Indian regulator, and the company anticipates approval in the coming weeks, he said.
“Now, in addition to all of this, we conducted trials in India and tested the vaccine for both safety and immunogenicity on the Indian population.” This data is currently being checked by the Indian regulator, and we expect it to be accepted in the coming weeks,” he said.
The All India Professional Congress (AIPC), Telangana, hosted a webinar on “India’s vaccination path and the second wave of Covid-19.”
According to Alexander Gintsburg, the head of the Gamaleya research institute that developed the vaccine, the Sputnik V vaccine has proved to be similarly successful for all age groups.
“In both age groups, Sputnik V showed the same degree of effectiveness. Initially, there were fears that effectiveness would be poorer in people aged 60 and over… but this was not the case “Gintsburg told the YouTube show SolovyovLive.
Sputnik V, according to the virologist, outperforms most coronavirus vaccines in terms of safety.
“Of the four to six vaccines that have gone into widespread use around the world, Sputnik V seems to rank first in terms of its qualities,” Gintsburg said.
